1. Home
  2. RLMD vs BZH Comparison

RLMD vs BZH Comparison

Compare RLMD & BZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

HOLD

Current Price

$6.93

Market Cap

752.1M

Sector

Health Care

ML Signal

HOLD

Logo Beazer Homes USA Inc.

BZH

Beazer Homes USA Inc.

HOLD

Current Price

$26.08

Market Cap

694.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLMD
BZH
Founded
2004
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
752.1M
694.0M
IPO Year
2012
1995

Fundamental Metrics

Financial Performance
Metric
RLMD
BZH
Price
$6.93
$26.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$12.40
$32.00
AVG Volume (30 Days)
869.6K
924.5K
Earning Date
05-08-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
45.28
N/A
EPS
N/A
N/A
Revenue
$13,070.00
$2,087,739,000.00
Revenue This Year
N/A
$4.36
Revenue Next Year
N/A
$10.79
P/E Ratio
N/A
N/A
Revenue Growth
154.83
N/A
52 Week Low
$0.52
$17.83
52 Week High
$8.00
$28.33

Technical Indicators

Market Signals
Indicator
RLMD
BZH
Relative Strength Index (RSI) 45.89 66.04
Support Level $6.81 $23.82
Resistance Level $7.46 $27.03
Average True Range (ATR) 0.42 1.11
MACD -0.04 0.36
Stochastic Oscillator 50.17 93.24

Price Performance

Historical Comparison
RLMD
BZH

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

About BZH Beazer Homes USA Inc.

Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in states and metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the sources of revenue for the company. Its segments involve: West segment that includes Arizona, California, Nevada, and Texas; East segment that includes Delaware, Indiana, Maryland, Tennessee, and Virginia; and Southeast segment which includes Florida, Georgia, North Carolina, and South Carolina.

Share on Social Networks: